CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- 4 Open-market buy President, CEO, COB bought 100 shares at $3.08 ($308)
- 8-K Event Shareholder rights changed
- 4 Open-market buy President, CEO, COB bought 300 shares at an average $3.01 ($903)
- 4 Open-market buy President, CEO, COB bought 1,800 shares at $2.99 ($5,375)
- 4 Open-market buy VP of Research and Development bought 943 shares at $2.62 ($2,467)
- 4 Open-market buy President, CEO, COB bought 1,000 shares at $2.88 ($2,877)
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy VP of Research and Development bought 725 shares at $3.39 ($2,457)
- 4 Open-market buy VP of Research and Development bought 806 shares at $3.69 ($2,973)
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 4 Open-market buy 10% owner bought 300 shares at $2.83 ($849)
Page 10 of 38 · 755 filings